Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
Temporary protective cover for an exposed junction box
Dynamic association and disassociation of threads to device functions based on requestor identification
Managing imaging of computing devices
Mobile terminal and controlling method thereof
Device and method for controlling brightness of organic light emitting diode display
Method and apparatus for transcoding and transrating in distributed video systems
  Randomly Featured Patents
Electrolytic process for manufacturing potassium peroxydiphosphate
Method of adjusting the flatness of a slider using selective plasma etching
Method and apparatus for detecting airlines in optical fibers
Lens-fitted photo film unit with stop changing device
Container with slide fastener
Patient privacy gown
Electronically controlled and monitored enclosure to dispense tobacco products
Pressure spray washer or the like
Coupling structures for a phase-locked laser array
Method and system for text placement when forming maps